Moderna Reports Third Quarter 2023 Financial Results and Provides Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Moderna (MRNA) drops after announcing a $3.1 billion charge, partially due to Covid writedowns
November 2, 2023 6:58 AM EDTModerna (NASDAQ: MRNA) shares fell about 2% in pre-market Thursday trade after the pharma company said its third-quarter results were impacted by a $3.1 billion charge related to resizing and a tax valuation allowance.
It includes $1.3 billion for inventory write-downs related to excess and obsolete COVID-19... More
Moderna (MRNA) Reports Wide Q3 Loss on $3.1B Charge, as Revenues Beat
November 2, 2023 6:36 AM EDTModerna (NASDAQ: MRNA) reported Q3 EPS of ($9.53), which may not compare to the analyst estimate of ($1.90). Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.4 billion.
Company has significantly improved future cost of sales by resizing its manufacturing... More
